Clinical Application of Targeted Next Generation Sequencing for Colorectal Cancers
Promising targeted therapy and personalized medicine are making molecular profiling of tumours a priority. For colorectal cancer (CRC) patients, international guidelines made RAS (KRAS and NRAS) status a prerequisite for the use of anti-epidermal growth factor receptor agents (anti-EGFR). Daily, new...
Main Authors: | Quitterie Fontanges, Ricardo De Mendonca, Isabelle Salmon, Marie Le Mercier, Nicky D’Haene |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/17/12/2117 |
Similar Items
-
Next-generation sequencing: recent applications to the analysis of colorectal cancer
by: Filippo Del Vecchio, et al.
Published: (2017-12-01) -
Design and Validation of a Gene-Targeted, Next-Generation Sequencing Panel for Routine Diagnosis in Gliomas
by: Nicky D’Haene, et al.
Published: (2019-06-01) -
Postoperative Circulating Tumor DNA Can Predict High Risk Patients with Colorectal Cancer Based on Next-Generation Sequencing
by: Chul Seung Lee, et al.
Published: (2021-08-01) -
Targeted Next Generation Sequencing for malaria research in Africa: current status and outlook
by: Anita Ghansah, et al.
Published: (2019-09-01) -
Targeted next‐generation sequencing of deaf patients from Southwestern China
by: Yunlong Li, et al.
Published: (2021-04-01)